Special Seminar: The Ongoing Development of Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder: Discussion of the Translational Process and Preliminary Results From a Recently Completed Phase-2 RCT

Gregory L. Sahlem, MD


Garrett, Angela


event sponsored by

Department of Psychiatry and Behavioral Sciences &

Department of Neurology, Duke Institute for Brain Sciences (DIBS), Neurobiology, and School of Medicine (SOM)


Psychiatry Special Seminar


Gregory L. Sahlem, MD

Dr. Gregory Sahlem is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He is a member of the Stanford Brain Stimulation Lab and directs the Addictions Research Section of the Lab. He is board-certified in general psychiatry and addiction medicine, as well as fellowship-trained in the research and clinical application of neuromodulation-based treatments including repetitive Transcranial Magnetic Stimulation (rTMS) and electroconvulsive therapy (ECT). He additionally has advanced training in the treatment of mood and sleep disorders. Among other endeavors, Dr. Sahlem has been involved in the early development of repetitive transcranial magnetic stimulation (rTMS) as a treatment of substance use disorders including cannabis, opioid, and tobacco use disorders. Link to attend: Passcode: 146759


Health/Wellness, Lecture/Talk, and Research